Introduction In the era of malaria elimination and eradication, drug-based and vaccine-based
approaches to reduce malaria transmission are receiving greater attention. Such …

Malaria parasites must undergo development within mosquitoes to be transmitted to a new
host. Antivector transmission-blocking vaccines inhibit parasite development by preventing …

Exosomes, also known as microvesicles (EMVs), are nano-sized membranous particles
secreted from nearly all mammalian cell types. These nanoparticles play critical roles in many …

Plasmodium parasites, the causative agents of malaria, have evolved a unique cell division
cycle in the clinically relevant asexual blood stage of infection 1. DNA replication …

Malaria sporozoites are deposited into the skin by mosquitoes and infect hepatocytes. The
molecular basis of how Plasmodium falciparum sporozoites migrate through host cells is …

Background Current SARS-CoV-2 detection platforms lack the ability to differentiate among
variants of concern (VOCs) in an efficient manner. CRISPR/Cas (Clustered Regularly …

Lymph node (LN) targeting through interstitial drainage of nanoparticles (NPs) is an attractive
strategy to stimulate a potent immune response, as LNs are the primary site for lymphocyte …

The idea of malaria transmission-blocking vaccines (TBVs) surfaced more than two decades
ago. Since then, the research paradigm focused on developing TBVs that target surface …

Malaria transmission entails development of the Plasmodium parasite in its insect vector, the
Anopheles mosquito. Parasite invasion of the mosquito midgut is the critical first step and …

Malaria transmission-blocking vaccines (TBVs) represent a promising approach for the
elimination and eradication of this disease. AnAPN1 is a lead TBV candidate that targets a …